Jun 24
|
Medigene Reports Results of Annual General Meeting
|
Jun 21
|
Medigene to Present at the Cell and Gene Therapy In-Depth Focus Summit 2024
|
Jun 20
|
Medigene AG Announces Lead Selection for MDG2021, Expanding TCR-T KRAS Library Targeting Solid Tumors
|
Dec 19
|
Medigene AG to attend at the 42nd Annual J.P. Morgan Healthcare Conference
|
Sep 5
|
Medigene AG to present at the H.C. Wainwright 25th Annual Global Investment Conference
|
Apr 27
|
Medigene AG to Present Expitope 3.0 at the 20th Annual Meeting of the Association for Cancer Immunotherapy (CIMT)
|
Apr 24
|
Medigene AG presents final Phase I data of TCR-T cell therapy MDG1011 in patients with high-risk blood cancers
|